VPIM
IMRX icon

Vanguard Personalized Indexing Management’s Immuneering IMRX Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-11,705
Closed -$25.8K – 1880
2024
Q4 		$25.8K Buy
+11,705
New +$24.3K ﹤0.01% 1749

Other funds holding IMRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SM
Southport Management Wilson, Wyoming $28.6M AUM 41.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Personalized Indexing Management's IMRX Position: Q1 2025 in Review

Vanguard Personalized Indexing Management sold out of Immuneering (IMRX) in Q1 2025, closing a stake of 11,705 shares — an estimated $25.8K sold.

Vanguard Personalized Indexing Management first reported a position in IMRX in Q4 2024 and held it in 1 quarter. The position peaked at $25.8K in Q4 2024. 35 funds tracked by Wall St. Rank hold IMRX as of Q1 2025.

  • Vanguard Personalized Indexing Management reported no remaining Immuneering position as of Q1 2025 after selling out during the quarter.
  • Vanguard Personalized Indexing Management sold 11,705 Immuneering shares in Q1 2025, an estimated $25.8K.
  • Vanguard Personalized Indexing Management first reported a position in Immuneering in Q4 2024 and held it in 1 quarter.
  • Vanguard Personalized Indexing Management's Immuneering position peaked at $25.8K in Q4 2024.
  • 35 funds tracked by Wall St. Rank held Immuneering as of Q1 2025.

Based on Vanguard Personalized Indexing Management's 13F filing for Q1 2025, filed 14 May 2025.